The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 6858384 B1

PDF
Full Text
Expired
Date of Patent:
Feb. 22, 2005

Filed:

May. 24, 2001
Applicants:

Leon W M M Terstappen, Huntingdon Valley, PA (US);

Ton Logtenberg, Utrecht, NL;

Inventors:

Leon W M M Terstappen, Huntingdon Valley, PA (US);

Ton Logtenberg, Utrecht, NL;

Assignee:

Crucell Holland B.V., CN Leinden, NL;

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12Q001/70 ; C12Q001/68 ; C12P021/04 ; C12N015/00 ; C07K001/00 ;
U.S. Cl.
CPC ...
Abstract

Peripheral blood leucocytes incubated with a semi-synthetic phage antibody library and fluorochrome-labeled CD3 and CD20 antibodies were used to isolate human single chain Fv antibodies specific for subsets of blood leucocytes by flow cytometry. Isolated phage antibodies showed exclusive binding to the subpopulation used for selection or displayed additional binding to a restricted population of other cells in the mixture. At least two phage antibodies appeared to display hithereto unknown staining patterns of B lineage cells. This approach provides a subtractive procedure to rapidly obtain human antibodies against known and novel surface antigens in their native configuration, expressed on phenotypically defined subpopulations of cells. Importantly, this approach does not depend on immunization procedures or the necessity to repeatedly construct phage antibody libraries.


Find Patent Forward Citations

Loading…